Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children
Clinical trial NCT02899702 · WITHDRAWN
Trial details
- NCT number
- NCT02899702
- Sponsor
- Hospices Civils de Lyon
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.